CEL-SCI
CVMCel-Sci Corporation (NYSE American: CVM), is a biotechnology company that is testing drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products. Cel-Sci's main product is the drug Multikine, an immunotherapeutic agent designed …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at CEL-SCI
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 5/8/2024 | Buy | Kersten, Geert R. | Chief Executive Officer | $1.4 | $41,700 |
| 5/8/2024 | Buy | Prichep, Patricia B. | Senior Vice President | $1.4 | $11,120 |
| 5/8/2024 | Buy | Watson, Robert Eugene | Director | $1.4 | $27,800 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)